Skip to main content
. 2020 May 5;10:7566. doi: 10.1038/s41598-020-64508-0

Figure 5.

Figure 5

NAT2 mRNA and protein expression in the cryopreserved human hepatocytes. Relative NAT2 mRNA and protein expression were quantified as described in the methods section. Each dot represents an individual sample. The line represents the median relative expression in the corresponding group. (a) Relative NAT2 mRNA expression in the rapid, intermediate and slow acetylation genotypes. (b) Relative NAT2 mRNA expression in specific rapid (NAT2*4/*4), intermediate (NAT2*4/*5; NAT2*4/*6) and slow (NAT2*5/*5; NAT2*6/*6) acetylator genotypes. (c) Relative NAT2 protein expression using monoclonal antibody ab194114, in the cryopreserved human hepatocytes of rapid, intermediate and slow acetylator NAT2 genotypes. (d) Relative NAT2 protein expression using monoclonal antibody ab194114, in rapid (NAT2*4/*4), intermediate (NAT2*4/*5; NAT2*4/*6) and slow (NAT2*5/*5; NAT2*6/*6) acetylator genotypes. *p < 0.05, **p < 0.01, ***p < 0.001.